[go: up one dir, main page]

EE04043B1 - H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks - Google Patents

H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks

Info

Publication number
EE04043B1
EE04043B1 EEP199900118A EE9900118A EE04043B1 EE 04043 B1 EE04043 B1 EE 04043B1 EE P199900118 A EEP199900118 A EE P199900118A EE 9900118 A EE9900118 A EE 9900118A EE 04043 B1 EE04043 B1 EE 04043B1
Authority
EE
Estonia
Prior art keywords
glucocorticoids
preparation
dosage form
atpase inhibitor
atpase
Prior art date
Application number
EEP199900118A
Other languages
English (en)
Estonian (et)
Other versions
EE9900118A (et
Inventor
Lennart Lindberg Per
Pinas-Masso Joan
Serra-Carreras Jordi
Trofast Jan
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900118A publication Critical patent/EE9900118A/xx
Publication of EE04043B1 publication Critical patent/EE04043B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
EEP199900118A 1996-10-11 1997-10-01 H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks EE04043B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603725A SE9603725D0 (sv) 1996-10-11 1996-10-11 New teatment
PCT/SE1997/001651 WO1998016228A1 (en) 1996-10-11 1997-10-01 USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS

Publications (2)

Publication Number Publication Date
EE9900118A EE9900118A (et) 1999-10-15
EE04043B1 true EE04043B1 (et) 2003-06-16

Family

ID=20404214

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900118A EE04043B1 (et) 1996-10-11 1997-10-01 H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks

Country Status (34)

Country Link
EP (1) EP0946175B1 (de)
JP (1) JP4100713B2 (de)
KR (1) KR100510812B1 (de)
CN (1) CN1146416C (de)
AR (1) AR008886A1 (de)
AT (1) ATE230597T1 (de)
AU (1) AU738310B2 (de)
BR (1) BR9711896A (de)
CA (1) CA2268305C (de)
CZ (1) CZ298799B6 (de)
DE (1) DE69718347T2 (de)
DK (1) DK0946175T3 (de)
EE (1) EE04043B1 (de)
ES (1) ES2188995T3 (de)
HK (1) HK1022848A1 (de)
HU (1) HUP0000036A3 (de)
ID (1) ID23692A (de)
IL (1) IL129324A0 (de)
IS (1) IS1930B (de)
MY (1) MY117918A (de)
NO (1) NO321007B1 (de)
NZ (1) NZ334786A (de)
PL (1) PL190902B1 (de)
PT (1) PT946175E (de)
RS (1) RS49599B (de)
RU (1) RU2197966C2 (de)
SA (1) SA97180641B1 (de)
SE (1) SE9603725D0 (de)
SK (1) SK284252B6 (de)
TR (1) TR199900770T2 (de)
TW (1) TW568784B (de)
UA (1) UA59374C2 (de)
WO (1) WO1998016228A1 (de)
ZA (1) ZA978842B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
RS50273B (sr) 1998-08-18 2009-07-15 The Regents Of The Univeristy Of California, Antagonisti receptora epidermalnog faktora rasta za lečenje hipersekrecije mukusa u plućima
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
DK1180378T3 (da) * 1999-03-03 2011-02-21 Optinose As Nasal administrationsindretning
US20050020637A1 (en) * 2001-11-19 2005-01-27 Wolfgang-Alexander Simon Agents for the treatment of airway disorders
PL370839A1 (en) * 2002-03-14 2005-05-30 Altana Pharma Ag Use of proton pump inhibitors for the treatment of airway disorders
JP2005526848A (ja) * 2002-05-07 2005-09-08 アルタナ ファルマ アクチエンゲゼルシャフト 気道疾患を治療するための組み合わせ
WO2003094967A2 (en) * 2002-05-07 2003-11-20 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
WO2004052374A1 (en) 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1670482B2 (de) 2003-09-16 2022-06-29 Covis Pharma B.V. Verwendung von ciclesonid zur behandlung von atemwegserkrankungen
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) * 2014-11-24 2017-09-26 广州供电局有限公司 单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) * 2017-04-10 2019-05-03 재단법인 아산사회복지재단 호산구성 비용종 동물모델
JP7614938B2 (ja) 2021-05-11 2025-01-16 日立Astemo株式会社 サスペンション制御装置、およびサスペンション制御方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate

Also Published As

Publication number Publication date
YU16399A (sh) 2000-03-21
MY117918A (en) 2004-08-30
SK38499A3 (en) 2000-03-13
EP0946175B1 (de) 2003-01-08
PT946175E (pt) 2003-04-30
AR008886A1 (es) 2000-02-23
JP4100713B2 (ja) 2008-06-11
SE9603725D0 (sv) 1996-10-11
HK1022848A1 (en) 2000-08-25
CN1232397A (zh) 1999-10-20
IS5021A (is) 1999-04-08
SA97180641B1 (ar) 2005-12-18
AU4640997A (en) 1998-05-11
CA2268305C (en) 2006-11-28
KR20000049046A (ko) 2000-07-25
UA59374C2 (uk) 2003-09-15
JP2001508034A (ja) 2001-06-19
RS49599B (sr) 2007-06-04
PL190902B1 (pl) 2006-02-28
EE9900118A (et) 1999-10-15
ATE230597T1 (de) 2003-01-15
WO1998016228A1 (en) 1998-04-23
EP0946175A1 (de) 1999-10-06
ES2188995T3 (es) 2003-07-01
CZ122999A3 (cs) 1999-09-15
ID23692A (id) 2000-05-11
HU0000036D0 (de) 2002-05-29
HUP0000036A2 (hu) 2002-05-29
DK0946175T3 (da) 2003-03-17
NO991619L (no) 1999-04-06
IL129324A0 (en) 2000-02-17
TR199900770T2 (xx) 1999-06-21
DE69718347D1 (de) 2003-02-13
IS1930B (is) 2004-05-18
ZA978842B (en) 1998-04-14
TW568784B (en) 2004-01-01
RU2197966C2 (ru) 2003-02-10
HUP0000036A3 (en) 2003-02-28
NO321007B1 (no) 2006-02-27
KR100510812B1 (ko) 2005-08-31
AU738310B2 (en) 2001-09-13
BR9711896A (pt) 1999-08-24
SK284252B6 (sk) 2004-12-01
CZ298799B6 (cs) 2008-02-06
CN1146416C (zh) 2004-04-21
CA2268305A1 (en) 1998-04-23
DE69718347T2 (de) 2003-08-28
NO991619D0 (no) 1999-04-06
PL332692A1 (en) 1999-09-27
NZ334786A (en) 2000-12-22

Similar Documents

Publication Publication Date Title
EE04043B1 (et) H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks
FI965039L (fi) Uusia trombiini-inhibiittoreita, niiden valmistus ja käyttö
FI963126L (fi) Stanoliseos ja sen käyttö
FI955235L (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
EE04500B1 (et) Trombiini inhibiitorid, nende saamine ja kasutamine
FI970920L (fi) Trifenyylietyleenejä käytettäväksi osteoporoosin ehkäisyyn ja hoitoon
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
HK1105580A1 (en) Use of isoflavone compounds in the manufacture of medicament and composition comprising the same
NO971764L (no) Levedyktige, forurensningspartikkelfrie adenoviruser, deres fremstilling og anvendelse
FI941378L (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
IS4394A (is) Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
FI951468L (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
ITTO930338A0 (it) Composizione adesiva, relativi procedimenti ed impiego
FI944600A0 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
FI990134L (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
BR9707808A (pt) Composto composição farmacêutica e uso do composto
FI944417L (fi) Atsoliyhdisteet, niiden valmistus ja käyttö
FI956298L (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
FI964936L (fi) Bentsopyraaneja ja niiden käyttö terapeuttisina aineina
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
FI941914A0 (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
FI964446L (fi) Uusia tetrapeptidejä, niiden valmistus ja käyttö

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20081001